| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000008018 |
| Receipt No. | R000009430 |
| Official scientific title of the study | Autonomic and Electrocardiographic Tests Study for Diagnosis in Patients with Syncope |
| Date of disclosure of the study information | 2012/06/01 |
| Last modified on | 2016/06/23 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Autonomic and Electrocardiographic Tests Study for Diagnosis in Patients with Syncope | |
| Title of the study (Brief title) | Autonomic and Electrocardiographic Tests Study for Diagnosis in Patients with Syncope | |
| Region |
|
|
| Condition | |||||
| Condition | Syncope | ||||
| Classification by specialty |
|
||||
| Classification by malignancy | Others | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | To evaluate diagnostic utility and utility of risk-stratification for traffic accident using autonomic and electrocardiographic tests in patients with syncope |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | syncope, presyncope |
| Key secondary outcomes | arrhythmic events, syncope/presyncope during driving |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Study subjects are patients with myocardial infarction, coronary spastic angina, idiopathic cardiomyopathy and pulmonary hypertension, who are stable disease condition, and are suspected as cardiogenic, vasogenic and neurally mediated syncope.
Control subjects are healthy volunteers. |
|||
| Key exclusion criteria | Exclusion criteria are:
unstable disease condition; other cause of syncope as like traumatic or neurological syncope, or hypoglycemia; patients who do not not accept study enrollment or are difficult to follow-up their clinical course. |
|||
| Target sample size | 250 | |||
| Research contact person | |
| Name of lead principal investigator | Yosuke Miwa |
| Organization | Kyorin University School of Medicine |
| Division name | Second Department of Internal Medicine |
| Address | 6-20-2 Shinkawa, Mitaka. Tokyo, Japan |
| TEL | +81-422-47-5511 |
| y-miwa@ks.kyorin-u.ac.jp | |
| Public contact | |
| Name of contact person | Yosuke Miwa |
| Organization | Arrythmia Center |
| Division name | Department of Cardiology |
| Address | 6-20-2 Shinkawa, Mitaka, Tokyo, Japan |
| TEL | +81-422-47-5511 |
| Homepage URL | |
| y-miwa@ks.kyorin-u.ac.jp | |
| Sponsor | |
| Institute | Second Department of Internal Medicine, Kyorin University School of Medicine |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | National Mutual Insurance Federation
of Agricultural Cooperatives |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | The Promotion of Mutual Aid Corporation for Private Schools of Japan |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 杏林大学医学部附属病院(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Prospective study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000009430 |